Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities
Zena Wehbe, Maya Wehbe, Rabah Iratni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication
Zheng Yao Low, Ashley Jia Wen Yip, Sunil K. Lal
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 2, pp. 166294-166294
Open Access | Times Cited: 42
Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis
Mario Cruciani, Ilaria Pati, Francesca Masiello, et al.
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1645-1645
Open Access | Times Cited: 32
Safety profile of COVID-19 drugs in a real clinical setting
Mei Nee Chiu, Maitry Bhardwaj, Sangeeta Pilkhwal Sah
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 5, pp. 733-753
Open Access | Times Cited: 21
N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19
Heidi N. du Preez, Colleen Aldous, Hendrik G. Kruger, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 21
A guide to COVID‐19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS‐CoV‐2 infection
Drugan K. Brady, Aashi R. Gurijala, Liyu Huang, et al.
FEBS Journal (2022) Vol. 291, Iss. 8, pp. 1632-1662
Open Access | Times Cited: 21
Repurposing of gastric cancer drugs against COVID-19
Charu Sonkar, Pawan Kumar Doharey, Anuranjan Singh Rathore, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104826-104826
Open Access | Times Cited: 22
SARS-CoV-2 and Coronavirus Disease Mitigation: Treatment Options, Vaccinations and Variants
Almu’atasim Khamees, Jamal Bani-Issa, Mazhar Salim Al Zoubi, et al.
Pathogens (2022) Vol. 11, Iss. 2, pp. 275-275
Open Access | Times Cited: 15
The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial
Shimaa A. Said, Alsayyed Abdulbaset, Amal A. El-Kholy, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
COVID-19: potential therapeutics for pediatric patients
Nour K. Younis, Rana Zareef, Ghina Fakhri, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1520-1538
Open Access | Times Cited: 19
Is Ivermectin Effective in Treating COVID-19?
Shuangshuang Yang, Shan Shen, Ning Hou
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids
Laura Fraccaroli, María D. Ruiz, Virginia Perdomo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 32, pp. 2660-2694
Closed Access | Times Cited: 10
The COVID-19 Pandemic: A Health Crisis Managed or a Panic Response with Disastrous Future Consequences?
Yunus A. Luqmani, Ahmed Z. El‐Hashim
Medical Principles and Practice (2021) Vol. 31, Iss. 1, pp. 1-10
Open Access | Times Cited: 12
Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model
Yun‐Ti Chen, Yu-Hsiu Chang, Nikhil Pathak, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis
Kentaro Shimizu, Haruhiko Hirata, Daijiro Kabata, et al.
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 4, pp. 548-553
Open Access | Times Cited: 10
Perspective: repurposed Drugs for COVID-19
Kesara Na‐Bangchang, Supattra Porasuphatana, Juntra Karbwang
Archives of Medical Science (2022) Vol. 18, Iss. 5, pp. 1378-1391
Open Access | Times Cited: 7
Phenotypic switch of vascular smooth muscle cells in COVID‐19: Role of cholesterol, calcium, and phosphate
Laura Ghanem, Dina Essayli, Jana Kotaich, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 12
Open Access | Times Cited: 1
Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein
Zhihong Wang, Naijing Hu, Yangyihua Zhou, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Modelling SARS-CoV-2 infection in a human alveolus microphysiological system
Tanja Šuligoj, Naomi S. Coombes, Catherine Booth, et al.
(2024)
Open Access
iThenticate Report for version 1

(2024)
Open Access
Editor response for version 1
Jana Katharina Schniete
(2024)
Open Access
Reviewer response for version 1
Tanja Šuligoj, Naomi S. Coombes, Catherine Booth, et al.
(2024)
Open Access
Reviewer response for version 1
Keith Grehan
(2024)
Open Access
Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease
Maryam Ali Khan, Guntaj Kaur Singh, Sakina Abrar, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 18, pp. 2455-2474
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top